Skip to content

Laparoscopy and COVID-19 Contamination

Laparoscopy and COVID-19 Contamination

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04608383
Acronym
LAPCOV
Enrollment
20
Registered
2020-10-29
Start date
2020-11-19
Completion date
2022-01-01
Last updated
2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

LAPAROSCOPY, pneumoperitoneum

Brief summary

The aim of the study is to search the presence of the SARS-COV-2 virus (COVID19) in the pneumoperitoneum of patients with a positive (or suspected) COVID19 status during a routine laparoscopy.

Interventions

OTHERAdditional and minimal collection of products of the human body carried out during a sample for standard of care

* Swab of the peritoneal fluid for traces of COVID19. The collection of peritoneal fluid is a standard care practice. * Swab from the laparoscopy filter

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient of legal age * Indication for laparoscopy * Positive (past or current) or suspected Covid19 status (cough, fever, suggestive radiological images, etc.) * Lack of opposition to participating in the study

Exclusion criteria

* Patient under legal protection * Covid19 status negative, (former or current) and not suspected * Patient unable to object * Patient with no social security care

Design outcomes

Primary

MeasureTime frameDescription
The main objective of the study is to demonstrate the presence of SARS-COV-2 in the exsufflated gas at the end of laparoscopy.Day 1 , at the end of the surgeryThe SARS-COV-2 will be looked for in the gas before its elimination at the end of the intervention. To this end, the PCR search will be carried out on the filter used

Secondary

MeasureTime frameDescription
The secondary objective of the study is to demonstrate the presence of SARS-COV-2 in the peritoneal fluid during laparoscopyDay 1 , at the end of the surgerySARS-COV-2 will be tested for by PCR in the peritoneal fluid collected during laparoscopy

Countries

France

Contacts

Primary ContactLaura RUSCIO
laura.ruscio@aphp.fr+3301 45 21 34 41

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026